Dr. Andrew A. Muskovitz
Claim this profileWilliam Beaumont Hospital-Royal Oak
Area of expertise
Colon Cancer
Andrew A. Muskovitz has run 2 trials for Colon Cancer. Some of their research focus areas include:
Colorectal Cancer
Andrew A. Muskovitz has run 2 trials for Colorectal Cancer. Some of their research focus areas include:
Affiliated Hospitals
William Beaumont Hospital-Royal Oak
William Beaumont Hospital - Troy
Clinical Trials Andrew A. Muskovitz is currently running
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting
2 awards
Phase 3
31 criteria
Atezolizumab + Chemotherapy
for Neuroendocrine Carcinoma
This trial is testing a new treatment combining an immune-boosting drug with standard chemotherapy for patients with a specific type of aggressive cancer that has spread. The goal is to help the immune system fight the cancer and use chemotherapy to kill cancer cells.
Recruiting
1 award
Phase 2 & 3
10 criteria
More about Andrew A. Muskovitz
Clinical Trial Related
5 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Andrew A. Muskovitz has experience with
- Atezolizumab
- Leucovorin Calcium, Fluorouracil, Oxaliplatin
- Bevacizumab
- Osimertinib
- Carboplatin
- Etoposide
Breakdown of trials Andrew A. Muskovitz has run
Colon Cancer
Colorectal Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew A. Muskovitz specialize in?
Andrew A. Muskovitz focuses on Colon Cancer and Colorectal Cancer. In particular, much of their work with Colon Cancer has involved Stage III patients, or patients who are Stage IV.
Is Andrew A. Muskovitz currently recruiting for clinical trials?
Yes, Andrew A. Muskovitz is currently recruiting for 5 clinical trials in Royal Oak Michigan. If you're interested in participating, you should apply.
Are there any treatments that Andrew A. Muskovitz has studied deeply?
Yes, Andrew A. Muskovitz has studied treatments such as Atezolizumab, Leucovorin Calcium, Fluorouracil, Oxaliplatin, Bevacizumab.
What is the best way to schedule an appointment with Andrew A. Muskovitz?
Apply for one of the trials that Andrew A. Muskovitz is conducting.
What is the office address of Andrew A. Muskovitz?
The office of Andrew A. Muskovitz is located at: William Beaumont Hospital-Royal Oak, Royal Oak, Michigan 48073 United States. This is the address for their practice at the William Beaumont Hospital-Royal Oak.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.